Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) EBT Margin (2016 - 2026)

Dexcom has reported EBT Margin over the past 17 years, most recently at 22.61% for Q1 2026.

  • Quarterly EBT Margin rose 772.0% to 22.61% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 24.98% through Mar 2026, up 736.0% year-over-year, with the annual reading at 23.35% for FY2025, 577.0% up from the prior year.
  • EBT Margin was 22.61% for Q1 2026 at Dexcom, down from 27.05% in the prior quarter.
  • Over five years, EBT Margin peaked at 29.13% in Q3 2025 and troughed at 5.74% in Q1 2022.
  • The 5-year median for EBT Margin is 18.7% (2024), against an average of 18.34%.
  • Year-over-year, EBT Margin skyrocketed 1542bps in 2022 and then tumbled -681bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 16.34% in 2022, then soared by 46bps to 23.8% in 2023, then decreased by -20bps to 18.98% in 2024, then surged by 43bps to 27.05% in 2025, then decreased by -16bps to 22.61% in 2026.
  • Per Business Quant, the three most recent readings for DXCM's EBT Margin are 22.61% (Q1 2026), 27.05% (Q4 2025), and 29.13% (Q3 2025).